Related Experiment Video
Updated: Aug 6, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Global Framework for Lip Product Safety: A Review of the Regulatory Blind Spot in the Modern Market
Laura DiGirolamo1,2, Heather Bustos3, Ke Chris Tang4
1Lip Service Alliance, 525 W 7TH Street, San Pedro, California, 90731 USA.
Abstract:
Lip products occupy a regulatory blind spot. Classified as cosmetics for external application across all major jurisdictions, there are two distinct adverse outcome pathways: cutaneous absorption via lip tissue with significantly diminished barrier function, and oral ingestion documented at levels reaching half a kilogram annually for high-frequency users. We present a comparative analysis of how the United States, European Union (EU), United Kingdom (UK), Canada, China, and South Korea regulate lip products, revealing a systemic gap in how regulations address their actual exposure profile. Three critical gaps are common across all frameworks: definitional miscategorization of the exposure profile; absence of appropriate safety assessment for either ingestion or lip-tissue absorption pathways; and testing duration requirements that are absent in the majority of frameworks and, where they exist, capped at subchronic endpoints that do not reflect continuous real-world use extending far beyond 90 days. Baseline exposure data underpinning global safety assessments were collected in 2003-2005 and predate contemporary lip product categories; contemporary studies document 95th-percentile lip balm consumption at 1,270 mg/day, a 14.6-fold increase over regulatory baselines. Two regulatory paradoxes within the EU crystallize the classificatory failure: titanium dioxide, banned as a food additive over oral ingestion genotoxicity concerns, remains unrestricted in lip cosmetics with an identical ingestion pathway; and microplastics are restricted in lip products under EU chemicals regulation because of environmental release through human ingestion, while the Cosmetics Regulation assesses them under dermal parameters. This demonstrates that regulatory sophistication cannot overcome classificatory error, and that meaningful reform requires updated, population-specific exposure studies reflecting contemporary usage patterns, product categories, and consumer demographics. We recommend development of lip-appropriate assessment methodology via validated non-animal methods (within existing cosmetic regulatory frameworks, without product reclassification) and the potential extension of the food-grade ingredient safety principles accepted in industry voluntary guidance to all lip product ingredient categories.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Drug Control Governance: Regulatory Bodies and Their Impact
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Preclinical Development: Overview
